Inhibikase Therapeutics, Inc.IKTNASDAQ
Loading
Cash generated from core business operations
Latest
$-25.62M
↓ 168% vs avg
Percentile
P0
Near historical low
Streak
7 yr
Consecutive declineContracting
Average
$-9.54M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-25.62M | -33.8% |
| 2024 | $-19.15M | -5.9% |
| 2023 | $-18.09M | -4.2% |
| 2022 | $-17.35M | -21.4% |
| 2021 | $-14.30M | -1165.9% |
| 2020 | $-1.13M | -233.8% |
| 2019 | $-338290.00 | -147.3% |
| 2018 | $714987.00 | +665.7% |
| 2017 | $-126391.00 | -327.4% |
| 2016 | $-29573.00 | - |